TOLERRX, Inc.
2Patents
0Active
2Granted
26Portfolio score
Filing activity: Jan 29, 2003 → Mar 27, 2006
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7812135B2 | GITR-binding antibodies | Emerging Cross-Sectional Technologies | 121 | Expired |
| US7541443B2 | Anti-CD4 antibodies | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.